| Identification |
| Name: | 19-Norpregna-1,3,5(10)-trien-20-yne-2,4,16,16-d4-3,17-diol,(17a)- (9CI) |
| Synonyms: | 17ALPHA-ETHYNYLESTRADIOL-2,4,16,16-D4;(17a)-19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol-d4;17a-Ethynylestradiol-d4;Amenoron-d4;Ethynylestradiol-2,4,16,16-d4;Eticyclin-d4;Eticylol-d4;Etivex-d4 |
| CAS: | 350820-06-3 |
| Molecular Formula: | C20H20 D4 O2 |
| Molecular Weight: | 300.43 |
| InChI: | InChI=1/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16?,17-,18?,19+,20+/m1/s1/i5D,11D2,12D |
| Molecular Structure: |
 |
| Properties |
| Melting Point: | 182-1840C |
| Flash Point: | 211.167°C |
| Boiling Point: | 457.223°C at 760 mmHg |
| Density: | 1.229g/cm3 |
| Refractive index: | 1.624 |
| Flash Point: | 211.167°C |
| Usage: | A synthetic steroid with high oral estrogenic potency |
| Safety Data |
| |
 |
